Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Ryan Nelson
L’Occitaine’s $900m Elemis buy will build out the manufacturer/retailer’s premium, natural-oriented beauty portfolio, adding a prestige brand that aspires to be a leader in global skin care with its nature/science balance and cross-generational consumer appeal.
On par with 2017, the Personal Care Products Council was tracking more than 300 state bills last year with potential implications for its members, including measures ultimately enacted by California and Hawaii to deter cosmetic animal testing and ban environmentally questionable sunscreens.
According to the NGO, not only are animals continuing to suffer in testing the Cosmetics Regulation’s animal-testing prohibitions were designed to eliminate, cruelty-free brands are having an increasingly difficult time avoiding animal-tested ingredients due to failings in the European Chemicals Agency’s administration of REACH.
With no end to the partial shutdown in sight, public safety concerns are mounting along with anxiety among furloughed employees. FDA Commissioner Gottlieb remains a vibrant presence on social media, working to maintain staff morale and reassure the public that critical agency functions carry on.
Despite repeated stakeholder assertions of being “closer than ever” to modernizing cosmetics regulations, the 115th Congress ended with reform legislation stranded in committee. The Personal Care Products says midterm elections diverted lawmakers’ attention from unresolved issues, likely including possible preemption terms to put a lid on growing state and local requirements.
Clarification of requirements and a “demanding” timeline for industry’s defense of cosmetic ingredients identified as potentially carcinogenic, mutagenic or reprotoxic, and the Commission’s forthcoming list of potential endocrine disruptors in cosmetic products, are among challenges facing Cosmetics Europe in 2019 and beyond.